Over the past several decades, radionuclides have matured from largely esoteric and
experimental technologies to indispensible components of medical diagnostics. Driving this …

Metallic radionuclides are the mainstay of both diagnostic and therapeutic
radiopharmaceuticals. Therapeutic nuclear medicine is less advanced but has tremendous …

Radiometals play an important role in diagnostic and therapeutic radiopharmaceuticals. This
field of radiochemistry is multidisciplinary, involving radiometal production, separation of the …

Metallic radionuclides have been instrumental in the field of nuclear imaging for over half a
century. While recent years have played witness to a dramatic rise in the use of radiometals …

Use of radiometals in nuclear oncology is a rapidly growing field and encompasses a broad
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …

This chapter reviews the radiopharmaceutical chemistry of technetium related to the
synthesis of perfusion agents and to the labeling of receptor-binding biomolecules. To …

Nuclear medicine is composed of two complementary areas, imaging and therapy. Positron
emission tomography (PET) and single-photon imaging, including single-photon emission …

The use of “non-standard” metallic radionuclides continues to be an expanding field of
investigation. Radiolabeling small molecules, peptides, proteins, and up to nano-particles …

Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems …

Chelators are necessary in nuclear medicine imaging to direct an inorganic radionuclide, a
radiometal, to a desired target; unfortunately, there is no 'one-size-fits-all'chelator. As the …